GB

David Woolfson

This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Woolfson. Retrieved from https://idiyas.com/inventor/david-woolfson-bgeo4fyv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: David Woolfson: Innovator in Pharmaceutical Gel Compositions

Introduction

David Woolfson is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceutical gel compositions. His work primarily focuses on estrogen compositions for vaginal administration and other topical applications.

Latest Patents

Woolfson's latest patents include "Estrogen Compositions For Vaginal Administration," which discloses pharmaceutical gel compositions containing estrogen for vaginal use, along with a method of making the same. Another notable patent is "Gel Compositions For Topical Administration," which details pharmaceutical gel compositions containing pharmacologically active agents for topical use, as well as a method of making these compositions.

Career Highlights

Throughout his career, David Woolfson has worked with prominent companies in the pharmaceutical industry. He has been associated with Allergan Pharmaceuticals International Limited and Warner Chilcott, LLC. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Woolfson has collaborated with several professionals in his field, including Karl Malcom and Jim Mcilroy. These collaborations have likely enhanced his research and development efforts in pharmaceutical gel compositions.

Conclusion

David Woolfson is a distinguished inventor whose work in pharmaceutical gel compositions has the potential to impact the medical field significantly. His innovative approaches to estrogen and topical gel formulations demonstrate his commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…